A multipronged approach to the identification and study of an important oncogene in GBM

Harley I Kornblum1

  • 1Intellectual and Developmental Disabilities Research Center and Department of Psychiatry, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. harley@ucla.edu

Cancer Cell
|May 19, 2010
PubMed

Insights

PLAGL2 acts as an oncogene in glioblastoma (GBM) by preventing cell differentiation and promoting self-renewal. This is partly achieved through activating Wnt signaling pathways, contributing to GBM progression.

Area of Science:

  • Molecular oncology
  • Cancer biology
  • Neuro-oncology

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.
  • Understanding the molecular drivers of GBM is crucial for developing targeted therapies.

Discussion:

  • PLAGL2 promotes a persistent, self-renewing state in GBM cells.
  • PLAGL2 inhibits crucial differentiation pathways in cancer cells.
  • Activation of Wnt signaling is implicated in PLAGL2-driven oncogenesis.

Key Insights:

  • Zheng et al. present compelling evidence for PLAGL2 as a GBM oncogene.
  • PLAGL2's role in maintaining cancer stem cell-like properties is highlighted.
  • The study links PLAGL2 to Wnt pathway activation in GBM.

Outlook:

  • Targeting PLAGL2 may offer a novel therapeutic strategy for GBM.
  • Further research into the PLAGL2-Wnt axis could reveal new treatment avenues.
  • Understanding PLAGL2's function could improve GBM patient outcomes.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...